Norway uses a broadly supported revised model which aim to be predictable, easy to calculate and consistent over time. The revised model was presented and accepted by LMI and Parallellimportørforeningen in 2020. Since 2021, the NMVS fee has been split between a flat fee and a sales-based fee. For 2024 the new model will be calculated as follows:

New entrants

New entrants will still be charged a new-entrant fee of NOK 15.000 in addition to the annual flat fee of NOK 33.500. Total for new entrants will therefore be NOK 48.500

Recurring participants

Since 2021, the NMVS fee is split between a flat fee and a sales-based fee. For 2024 the fee will be calculated as follows:

1. A flat fee of NOK 33.500 per. MAH, plus
2. A fee based on reported (actual) sales (aka. GIP) for 2023 of 0,033% of sales. The fee will be calculated based on net sales (as reported to the NCA). For companies that have not reported net actual sales we will use sales data (AIP) as reported from the pharmacies.